To investigate whether altered megakaryocyte morphology contributes to reduced platelet production in idiopathic thrombocytopenic purpura (ITP), ultrastructural analysis of megakaryocytes was performed in 11 ITP patients. Ultrastructural abnormalities compatible with (para-)apoptosis were present in 78 ± 14% of ITP megakaryocytes, which could be reversed by in vivo treatment with prednisone and intravenous immunoglobulin.
Abstract
To investigate whether altered megakaryocyte morphology contributes to reduced platelet production in idiopathic thrombocytopenic purpura (ITP), ultrastructural analysis of megakaryocytes was performed in 11 ITP patients. Ultrastructural abnormalities compatible with (para-)apoptosis were present in 78 ± 14% of ITP megakaryocytes, which could be reversed by in vivo treatment with prednisone and intravenous immunoglobulin.
Immunohistochemistry of bone marrow biopsies of ITP patients with extensive apoptosis showed an increased number of megakaryocytes with activated caspase-3 compared to normal (28 ± 4% versus 0%). No difference, however, was observed in the number of bone marrow colony-forming units-megakaryocyte (ITP: 118 ± 93 versus controls: 128 ± 101; p=0.7). To demonstrate that circulating antibodies might affect megakaryocytes, suspension cultures of
CD34
+ cells were performed with ITP or normal plasma. Morphology compatible with (para-)apoptosis could be induced in cultured megakaryocytes with ITP plasma (2/10 samples positive for antiplatelet autoantibodies). Finally, the plasma glycocalicin-index, a parameter of platelet and megakaryocyte destruction, was increased in ITP (57 ± 70 versus 0.7 ± 0.2; p=0.009) and correlated with the proportion of megakaryocytes showing (para-)apoptotic ultrastructure (p=0.02; r=0.7). In conclusion, the majority of ITP megakaryocytes show ultrastructural features of (para-)apoptosis, probably due to action of factors present in ITP plasma.
Introduction
Idiopathic or immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by isolated thrombocytopenia in an otherwise healthy person. The thrombocytopenia in ITP is caused by accelerated platelet destruction due to the action of antiplatelet IgG-autoantibodies that bind to antigens on the platelet cell membrane. The platelets are subsequently destroyed by tissue macrophages, predominantly in the spleen 1 . As a result of the accelerated destruction, platelet survival is usually greatly shortened and platelet production is thought to be compensatory increased 2, 3 . However, there is also evidence that platelet production can be impaired in ITP. This was demonstrated in platelet kinetic studies using radiolabeled platelets [4] [5] [6] . The reduced platelet production rate might be mediated by the action of antiplatelet antibodies, which can bind to megakaryocytes in the bone marrow [7] [8] [9] . Recent in vitro studies support this concept showing that human megakaryocyte colony formation and proplatelet formation is inhibited 10 and that a reduced expansion of megakaryocytic progenitors can be observed especially in the presence of certain antiplatelet glycoprotein antibodies 11 . However, despite the evidence of a reduced platelet production in several ITP patients, numbers of megakaryocytes in the bone marrow are usually normal or increased 6 . This is compatible with the finding that plasma thrombopoietin (TPO) levels in ITP patients are not significantly different from normal controls, indicating that the total megakaryocytic mass has not been changed in ITP.
Investigating the relationship between thrombokinetic parameters and the glycocalicin-index (GCI), a parameter of platelet destruction 12 , we recently demonstrated that there is an inverse correlation between the platelet production rate and the GCI 13 . These results suggest that despite the normal number of megakaryocytes in the bone marrow an increased destruction of platelets and/or megakaryocytes might occur. These findings support the concept of 
Materials and Methods

Patients
Eleven adult patients with ITP were investigated. The diagnosis required that an otherwise healthy person, after history, physical examination, complete blood count, and examination of the peripheral blood smear, had an isolated thrombocytopenia (platelets < 100 x 10 9 /L) of undetermined etiology. Patients with associated systemic disease, such as human immunodeficiency virus infection or systemic lupus erythematosus, were excluded.
Light microscopy of the bone marrow megakaryocytes
In all patients bone marrow was aspirated from the sternum or posterior superior iliac spine and stained according to Giemsa. Normal bone marrow was obtained from non-hematological patients undergoing cardiac surgery after informed consent. The number of megakaryocytes was rated as normal [1 megakaryocyte per 1 to 3 low power fields (16x objective)], increased (>2 megakaryocytes per low power field), or decreased (1 megakaryocyte per 5 to 10 low power fields) 6 . Megakaryocyte morphology was studied with a 100x objective. The Golgi complex and RER are greatly reduced 14 .
Electron microscopy of bone marrow megakaryocytes
A total of 30 megakaryocytes per sample were examined.
Ultrastructural characteristics of apoptosis and para-apoptosis
The ultrastructure of megakaryocytes was examined for the presence of apoptotic and paraapoptotic cell death.
Ultrastructurally apoptosis is characterized by margination of condensed chromatin, nuclear fragmentation and the formation of apoptotic bodies 15 .
Para-apoptosis or non-classical apoptosis is a specific morphological type of nonnecrotic cell death [16] [17] [18] and is characterized by cytoplasmic vacuolization, condensed chromatin (but not early margination of the chromatin) and swollen mitochondria.
Characteristics of apoptosis like surface blebbing and the formation of apoptotic bodies do not appear.
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Immunohistochemistry
To identify apoptosis in megakaryocytes, immunohistochemical staining was performed with an antibody aimed at detecting activated caspase-3 as previously reported 19 . For immunohistochemical staining, serial 3 µm-thick -sections were cut from paraffin embedded bone marrow biopsies. After deparaffinization in xylene, antigen retrieval was performed using microwave heating at 700 W for 10 minutes in EDTA buffer. Following blocking of endogenous peroxidase with 3% hydrogen peroxide for 30 min, the primary antibody was applied for 1 h at room temperature. To identify activated caspase-3, immunostaining was used with a rabbit polyclonal antibody (1:100, New England Biolabs, Beverly MA, USA).
Subsequently, the slides were incubated for 30 minutes with appropriate secundary and tertiary antibodies with streptavidin-conjugated peroxidase (DAKO, Glostrup, Denmark).
Peroxidase activity was visualised with diaminobenzidine. Slides were counterstained with haematoxylin. As a positive control, a sample of colorectal carcinoma was included. As negative controls, slides were immunostained in the absence of the primary antibody.
Evaluation of extension of staining was performed by light microscopy. Slides were evaluated by at least two independent investigators. If the evaluations did not agree they were reevaluated under a multi-headed microscope. Samples were scored as negative (i.e. absence of detectable cytoplasmic staining) or positive. A total of 30 megakaryocytes per sample were examined.
Megakaryocyte progenitor cell assay
Colony-forming units-megakaryocyte (CFU-Mk) were evaluated quantitatively using a commercially available kit (MegaCult-C; Stem Cell Technologies, Vancouver, Canada), according to manufacturer's instructions. In short, 1 x 10 5 mononuclear bone marrow cells from ITP patients and normal controls were seeded per double chamber culture slide in
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From serum-free medium containing thrombopoietin (TPO; 50 ng/mL), interleukin (IL)-3 (10 ng/mL), IL-6 (10 ng/mL) and collagen (1.1 mg/mL). Cultures were incubated for 12 days, followed by dehydration, fixation and immunocytochemical staining on slides.
Megakaryocyte colonies were detected using anti-glycoprotein (GP)IIb/IIIa antibody (CD41) and the alkaline phosphatase detection system (APAAP). Cultures were scored for the presence of pure megakaryocytic colonies consisting of at least five nucleated cells expressing GPIIb/IIIa without any negatively stained cells (mixed and non-Mk colonies). Colonies were divided into megakaryocyte progenitors with low-proliferative capacity, when colonies contained 5-20 megakaryocytes, and progenitors with high-proliferative capacity, when CFUMk contained more than 20 megakaryocytes per colony 20 .
Isolation of CD34 + cells
Peripheral blood cells were obtained from leucapheresis samples of a patient undergoing autologous peripheral blood stem cell mobilization after informed consent. Cells were collected by apheresis during the regeneration phase after high-dose cyclophosphamide in the presence of granulocyte colony-stimulating factor (G-CSF) in patients with multiple myeloma. CD34 + cells were isolated by positive selection using Isolex-300 (Baxter, Deerfield, IL, USA) magnetic cell sorting system according to manufacturer's instructions. At the end of the procedure, CD34 + cell purity was reanalysed by flow cytometry using anti-HPCA-2 and was greater than 90%.
Suspension cultures
Purified normal CD34 + cells were seeded at 2 x 10 5 cells/ml in liquid serum free expansion medium (StemSpan SFEM; Stem Cell Technologies, Vancouver, Canada) plus growth factors (TPO 20 ng/mL and stem cell factor (SCF) 10 ng/mL) in 24-well plates (Costar,
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Cambridge, MA, USA). Cultures were performed for 7 and 12 days in the presence of 10% plasma from ITP patients, 10% plasma from normal controls and without plasma. All cultures were performed at 37°C under a 5% CO 2 in air-humidified atmosphere. Viable cells were evaluated by trypan blue exclusion and cell counts were determined using a haemocytometer.
Antiplatelet antibody detection
A commercially available ELISA (PakAuto , GTI, Brookfield, USA) was used to detect antibodies reactive with GPIIb/IIIa, GPIb/IX and GPIa/IIa in plasma of ITP patients according to manufacturer's instructions. Test results showing absorbance values equal or greater than twice the value obtained for the mean of the negative controls were regarded as positive.
Plasma glycocalicin
Plasma glycocalicin (GC) concentrations were measured by EIA (Takara Shuzo Co, Ltd., Ohtsu, Japan). Citrate-anticoagulated blood was processed within 2 hours after blood collection. Since GC levels are dependent on the platelet count, the GC-index (GCI) was calculated by using the following formula: [GC (µg/mL) x (250 x 10 9 /L)]/individual platelet count (10 9 /L) 12, 21 . Normal value of the GCI is 0.7 ± 0.2.
Statistical analysis
Data are reported as mean ± SD. Differences between groups were calculated using the MannWhitney U-test. Correlations were calculated using Spearman's rank correlation test. P-values below 0.05 were considered significant.
Results
Patients
Eight female and 3 male patients with ITP were studied. Mean age was 34 ± 19 years. The mean platelet count at the time of study was 21 ± 30 x 10 9 /L. Eight patients (73%) had platelet counts < 15 x 10 9 /L (Table 1) . During the time of study no patients were on treatment. Four patients had undergone a splenectomy before they were studied.
Light microscopy of bone marrow megakaryocytes
Eight patients (73%) had an increased number and 3 patients a normal number of megakaryocytes in the bone marrow. In smears made from bone marrow aspirates for clinical use no abnormalities were found in megakaryocyte morphology. In more than 90% of the abnormal megakaryocyes all ultrastructural characteristics of apoptosis and para-apoptosis were found. The amount and type of alterations in the megakaryocytes were not correlated with the platelet count.
Electron microscopy and immunohistochemistry of bone marrow megakaryocytes
ITP patients versus normal controls
To confirm the process of apoptosis immunohistochemical staining for activated caspase-3 was performed on bone marrow biopsies from ITP patients (n=2; nrs 6 and 10, see Table 1 ) whose megakaryocytes showed ultrastructurally prominent morphological features of apoptosis. Twentyfive and 30% of the megakaryocytes of these ITP patients were positive for activated caspase-3, while megakaryocytes of bone marrow biopsies from normal controls (n=4) were negative ( Figure 4 ).
ITP patients before and after treatment
In two patients the effects of prednisone or high-dose immunoglobulin could be analysed. In the first patient the bone marrow aspiration was repeated 2 weeks after start of prednisone treatment. In this period the platelet count had significantly increased to 120 x 10 9 /L. 
Quantification of megakaryocyte progenitor cells
In view of the observed abnormalities in immature megakaryocytes, we were interested whether this was also reflected at progenitor level, i.e. a reduced number of megakaryocyte progenitors (CKU-Mk). The total number of CKU-Mk per 10 5 bone marrow cells in ITP was not significantly different from normal controls (n=10) (118 ± 93 vs 128 ± 101; p=0.7). In addition, there was no significant difference in the number of progenitors with low-and highproliferative capacity between ITP and normal control bone marrow (p=0.7 and 0.9, respectively).
Megakaryocytes derived from CD34 + cells after incubation with normal and ITP plasma
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To investigate whether normal megakaryocytopoiesis can be influenced by factors in ITP plasma, normal CD34 + cells were incubated with 10% plasma from 3 ITP patients (nrs 1, 2 and 10; Table 1 ) and 3 normal controls and cultured for 7 and 12 days in serum-free medium containing TPO and SCF. After 7 days incubation with ITP or normal plasma, electron microscopy of the suspension cultures showed only immature megakaryocytes without abnormalities. After 12 days of culture similar cytoplasmic and nuclear alterations as observed in the ITP megakaryocytes were seen in 60 ± 14% of the megakaryocytes derived from incubation with ITP plasma (42 ± 23% with apoptotic and 18 ± 9% with para-apoptotic ultrastructure). Ninety percent of megakaryocytes incubated with normal plasma were morphologically normal and ultrastructural features of para-apoptosis were not observed.
Antiplatelet antibodies
Plasma from 2/10 patients tested positive for the presence of antiplatelet antibodies (Table 1 ).
Plasma used for incubation studies was derived from patients nrs 1, 2 and 10. The plasma from patient nr 2 tested positive for antibodies reactive with GPIIb/IIIa, GPIb/IX and GPIa/IIa. In the plasma of the other 2 patients test results for antibodies were negative.
Plasma GCI
GCI in ITP patients (n=10) was significantly increased compared to normal controls (n=16) (57 ± 70 vs 0.7 ± 0.2; p=0.009) ( Table 1 ). There was a significant correlation between the GCI and the proportion of ITP megakaryocytes with morphological features of (para-) apoptosis (p=0.02; r=0.7) ( Figure 5 ).
Discussion
In the present study extensive ultrastructural alterations in megakaryocytes from ITP patients are described. Previous studies on megakaryocyte morphology and ultrastructure in ITP show conflicting results. Earlier light microscopic observations showed megakaryocytes with degenerative characteristics and greatly reduced platelet production, although the number of megakaryocytes was increased in ITP patients compared to normal 22 . Ultrastructural studies of megakaryocytes in ITP showed results varying from moderate vacuolization, deficient formation of demarcation membrane system (DMS) and invaginations in the peripheral membrane 22 to practically normal morphology of megakaryocytes 24, 25 . Stahl et al 26 found that 50 to 75% of the ultrastructurally examined megakaryocytes from 4 ITP patients had extensive damage, with marked dilatation of the DMS and a disrupted peripheral zone. ITP megakaryocytes with an intact peripheral zone did not show any morphological alterations.
The present investigation, however, reveals ITP megakaryocytes with extensive abnormalities within an intact and often thickened peripheral zone. These cells are all surrounded by neutrophils and macrophages, suggesting an inflammatory response against these megakaryocytes.
The ultrastructural alterations observed in the present study are compatible with the morphological criteria for apoptosis and para-apoptosis. Para-apoptosis, first described by Asher et al 16 , is characterized by condensed chromatin and cytoplasmic vacualization due to swollen mitochondria and endoplasmic reticulum. In contrast to necrosis there is no cell membrane disruption. Recently, Sperandio et al defined a form of para-apoptosis (which they called paraptosis) with similar ultrastructure by cellular characteristics and response to apoptosis inhibitors 18 . They found that this form of nonapoptotic cell death is TUNEL (terminal deoxynucleotidyl transferase-mediated nick end labeling)-negative and resistant to
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caspase-inhibitors and Bcl-x L , and is driven by a catalytic mutant of caspase-9 that is APAF-1 independent.
In our study about 80% of mature (stage III) megakaryocytes, in which most of the platelet production occurs, showed ultrastructural features of apoptosis and para-apoptosis.
Significantly less stage I megakaryocytes showed morphological alterations, indicating that immature megakaryocytes are less affected by (para-)apoptotic cell death. This is further supported by the finding that the total number of CFU-Mk in our ITP patients was not significantly different from normal. Previous studies on the number of CFU-Mk in chronic ITP showed conflicting results, depending on the assay that was used, the stage (acute or chronic) of the disease and the refractoriness of the ITP to therapy. Several authors 27, 28 found a significant increase in number of CFU-Mk in chronic ITP patients. Others 29, 30 reported a reduced number of CFU-Mk in chronic ITP. The present group of ITP patients was heterogeneous, consisting of patients responding to prednisone and splenectomy and patients with recurrent disease after splenectomy.
Morphological changes compatible with (para-)apoptosis similar to those found in megakaryocytes from ITP patients could be induced in normal CD34 + cells that were cultured to megakaryocytes in the presence of ITP plasma. The data from these incubation studies are consistent with earlier phase-contrast microscopic studies of ITP megakaryocytes in which cytoplasmic vacuolization, loss of granularity and lack of platelet release were observed. In these studies the morphological alterations in the megakaryocytes could be reproduced in vivo by infusing healthy controls with ITP plasma 31 . The results suggest that the defect in ITP is not only at the level of platelets but also at the level of megakaryocytes. This is further supported by the finding that during successful treatment with prednisone the number of damaged megakaryocytes decreases. Suprisingly, this was also the case in an ITP patient treated with intravenous immunoglobulin, indicating that this treatment not only protects
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From peripheral blood platelets from destruction by macrophages but might also protect megakaryocytes against destruction by bone marrow macrophages. A possible explanation for this finding could be a reduced concentration of antiplatelet antibodies, since recent observations in a rat model of immune thrombocytopenia showed that intravenous immunoglobulin administration can lead to increased clearance of an antiplatelet antibody 32 .
Since antiplatelet antibodies bind to antigens present on the surface of megakaryocytes 8 it is likely that this interaction plays an important role in initiating the cascade of programmed cell death. However, in only 20% of ITP patients plasma antiplatelet antibodies were detected.
This may in part be due to the limited sensitivity of the ELISA test for detecting antiplatelet autoantibodies. Previous studies, however, have also demonstrated a low frequency of free circulating autoantibodies 33 , suggesting that alternative mechanisms for initiating cell death are of importance, including the release of cytokines 34 .
The presence of extensive ultrastructural abnormalities in megakaryocytes indicates that ITP is essentially different from other autoimmune cytopenias such as autoimmune hemolytic anemia (AIHA). In contrast to AIHA, which presents in practically all cases with clear erythroid hyperplasia 35, 36 , bone marrow examination in ITP shows normal numbers of megakaryocytes in a large number of patients 37 , suggesting that ITP megakaryocytes might be affected contrary to erythroid precursors in AIHA. Only a small proportion of AIHA patients has reticulocytopenia, which is associated with an increased apoptosis of erythroid progenitors in the bone marrow 38 .
In a recent study 6 megakaryocyte levels were normal in 65% of 141 ITP patients and increased in only 33%. Twenty-four percent had an increased platelet production rate (PPR,
i.e. the number of platelets entering the circulation), and only 8% had an increased PPR in conjunction with an increased number of megakaryocytes. Moreover, there are many reports about a reduced PPR in a subgroup (30-50%) of ITP patients 4, 5, 6, 39, 40 . Experiments in which thrombokinetic studies were repeated after splenectomy and prednisone treatment showed that both forms of treatment can induce a distinct increase in PPR 41 , indicating that the release of platelets to the circulation (i.e. PPR) in active ITP is relatively depressed, perhaps due to the action of autoantibodies directed against megakaryocytes.
Besides the results of reduced platelet production in platelet kinetic studies the present study gives additional evidence for reduced platelet production by injured megakaryocytes. In a recent study 13 we observed a significant inverse correlation between the PPR and the glycocalicin-index (GCI) in ITP patients. The GCI is used as a parameter of platelet destruction. A low PPR is associated with an elevated GCI. These findings reflect an increased release of GPIb-complex in the circulation, as a result of shedding of the receptor complex from megakaryocytes and/or platelets destructed in the bone marrow. In the present data a significant correlation was observed between the percentage of megakaryocytes in programmed cell death and the GCI, underscoring the view that the low PPR in ITP might be due to an increase in (para-)apoptosis of platelet producing megakaryocytes.
In summary, the present study demonstrates that in ITP patients a large majority of morphologically recognizable megakaryocytes show ultrastructural alterations compatible with (para-)apoptosis, which can be mimicked by incubating normal differentiated CD34 
